Measuring SPIO and Gd contrast agent magnetization using 3 T MRI

No abstract is available for this paper.

• Publication year

  2009

• Venue

  NMR in Biomedicine

• Publication date

  2009-05-01

• Fields of study

  Materials Science, Medicine, Physics, Chemistry

• Identifiers
  DOI 10.1002/nbm.1412PMID 19588450PMCID PMC3190601
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Susceptibility-Weighted MR Imaging: A Review of Clinical Applications in Children

  2008cited by this paper
• Labeling of cells with ferumoxides–protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells

  2005cited by this paper
• Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis

  2004cited by this paper
• Iron oxide MR contrast agents for molecular and cellular imaging

  2004influential reference
• Electromagnetic Field Theory: A Problem Solving Approach

  2003cited by this paper
• Application of the static dephasing regime theory to superparamagnetic iron‐oxide loaded cells

  2002cited by this paper
• The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds.

  1996cited by this paper
• Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil.

  1995cited by this paper
• MRI susceptometry: Image‐based measurement of absolute susceptibility of MR contrast agents and human blood

  1992influential reference
• Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues.

  1990cited by this paper
• Bulk magnetic susceptibility shifts in nmr studies of compartmentalized samples: use of paramagnetic reagents

  1990cited by this paper
• Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging.

  1990cited by this paper
• Transverse relaxation of solvent protons induced by magnetized spheres: Application to ferritin, erythrocytes, and magnetite

  1987cited by this paper
• Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent.

  1984cited by this paper
• Human Brain Mapping 5:341–346(1997) � In Vivo Measurement of Blood Oxygen Saturation Using Magnetic Resonance Imaging: A Direct Validation of the Blood Oxygen Level-Dependent Concept in Functional Brain Imaging

  year unknowncited by this paper

• Enhancing organ and vascular contrast in preclinical ultra-low field MRI using superparamagnetic iron oxide nanoparticles

  2024cites this paper
• Enhanced 129Xe T1 relaxation in whole blood and in the presence of SPIONs at low magnetic field strengths

  2023cites this paper
• Zwitterionic neurotransmitter-sensitive gadolinium complex as a potential MRI contrast agent for Alzheimer’s disease diagnosis

  2022cites this paper
• Effect of synthetic conditions on the crystallinity, porosity and magnetic properties of gluconic acid capped iron oxide nanoparticles

  2020cites this paper
• Iron (III)-Quercetin Complex: Synthesis, Physicochemical Characterization, and MRI Cell Tracking toward Potential Applications in Regenerative Medicine

  2020cites this paper
• High-sensitivity in vivo contrast for ultra-low field magnetic resonance imaging using superparamagnetic iron oxide nanoparticles

  2020cites this paper
• Evolution of gluconic acid capped paramagnetic iron oxide nanoparticles

  2019cites this paper
• Superparamagnetic Gold Nanoparticles Synthesized on Protein Particle Scaffolds for Cancer Theragnosis

  2017cites this paper
• Tracking and Quantification of Magnetically Labeled Stem Cells Using Magnetic Resonance Imaging

  2016cites this paper
• Quantitative assessment of microvasculopathy in arcAβ mice with USPIO-enhanced gradient echo MRI

  2015cites this paper
• Quantitative Analysis of Superparamagnetic Contrast Agent in Sentinel Lymph Nodes Using Ex Vivo Vibrating Sample Magnetometry

  2013cites this paper
• Magnetic susceptibility as a B0 field strength independent MRI biomarker of liver iron overload

  2013cites this paper
• PEGylated FePt@Fe2O3 core-shell magnetic nanoparticles: potential theranostic applications and in vivo toxicity studies.

  2013cites this paper
• Magnetic nanoparticles for imaging technology

  2013cites this paper
• Quantitative susceptibility mapping and susceptibility-based distortion correction of echo planar images

  2012cites this paper
• Magnetic susceptibility derived from T2 and T 2*‐weighted magnetic resonance magnitude images

  2012cites this paper
• Quantification of SPIO nanoparticles in vivo using the finite perturber method

  2011cites this paper